Muscle Symptoms Associated with Statins: A Series of Twenty Patients
Open Access
- 24 January 2006
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 98 (1) , 51-54
- https://doi.org/10.1111/j.1742-7843.2006.pto_193.x
Abstract
The aim of this study was to examine the clinical profile of statin-induced myalgia in patients with no apparent predisposing factors. Patients who reported muscle complaints that limited daily functioning during statin use were prospectively identified among the patients of Kuusankoski District Hospital and its catchment area, a population of about 100,000, between January 2003 and July 2004. Twenty patients in whom the muscle complaints were probably attributable to the use of a statin were included in this series. There were no cases of severe myopathy or rhabdomyolysis, and the highest creatine kinase value observed was only about 1900 U/l. Of the 18 patients that were evaluable for creatine kinase level, 5 (28%) did not exhibit elevation of creatine kinase and 6 (33%) showed a minor increase only. Following discontinuation of the statin, resolution of symptoms and normalisation of creatine kinase occurred in 11 of the 13 patients with elevated creatine kinase value as well as muscle complaints. Statins may cause clinically important muscle symptoms without inducing a marked creatine kinase elevation.Keywords
This publication has 15 references indexed in Scilit:
- Statin-Associated MyopathyJAMA, 2003
- Statin-Associated Myopathy with Normal Creatine Kinase LevelsAnnals of Internal Medicine, 2002
- ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of StatinsCirculation, 2002
- Isoprenoids as mediators of the biological effects of statinsJournal of Clinical Investigation, 2002
- Effects of HMG-CoA Reductase Inhibitors on Skeletal MuscleDrug Safety, 2002
- Rhabdomyolysis and HMG-CoA Reductase InhibitorsAnnals of Pharmacotherapy, 2001
- Statin—Fibrate Combination TherapyAnnals of Pharmacotherapy, 2001
- Metabolism and Drug Interactions of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors in Transplant Patients: Are the Statins Mechanistically Similar?Pharmacology & Therapeutics, 1998
- The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/DayThe American Journal of Cardiology, 1997
- Myopathy associated with lipid lowering therapy in patients with previously undiagnosed or undertreated hypothyroidismClinica Chimica Acta; International Journal of Clinical Chemistry, 1996